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Disease occurs due to aberrant expression of genes and modulation of the biological pathways along which they
lie. Inference of activated gene pathways, using gene expression data during disease progression, is an important
problem. In this work, we have developed a generalizable framework for the identification of interacting pathways while
incorporating biological realism, using functional data analysis and manifold embedding techniques. Additionally, we
have also developed a new method to query for the differential co-ordinated activity of any desired pathway during
disease progression. The methods developed in this work can be generalized to any conditions of interest.
Keywords: Functional Data Analysis (FDA), Gene ontology, immune response, Laplacian Eigenmaps, Mantel corre-
lation, logDet divergence, functional genomics, heterogeneous data integration.
1. INTRODUCTION
A gene is a segment of the genome (DNA) that codes
for protein. Proteins are the biological catalysts of
function and mediate the kinetics and timing of any
biological process. The body is composed of several
tissues and each tissue has its own individual lineage
of cells. The set of proteins that are active in each cell
are different depending on cell context and the under-
lying function of the cell. Since proteins are encoded
by the gene(s), it is believed that biological processes
are orchestrated by a precise spatio-temporal expres-
sion of genes. Gene activities in the cell are organized
along pathways, which might either have signaling
activity or regulatory role in determining cell behav-
ior. Thus even though there is a heterogeneous pop-
ulation of cells in the body, each set of cells has a
precise time and location of gene/pathway expres-
sion corresponding to required protein activity.
Systemic disease can occur due to the mis-
expression of genes in various tissues [as an example,
the Gata3 gene is mutated in HDR (hypoparathy-
roidism, deafness, renal dysplasia)]. A lot of studies
have studied the link between the genome and the
phenome - i.e. between gene expression and physical
characteristic. Disease (and its symptoms) is a physi-
cal characteristic which arises from mis-expression of
the underlying genome. Also, very rarely is disease
due to the aberrant expression of a single gene - they
mostly arise due to mis-expression of several genes at
once (i.e. gene sets). Identifying these set of aber-
rant genes (or pathways) is an important problem
because of the immense therapeutic potential. There
is an ongoing effort to find inhibitors that can tar-
get disease-implicated pathways. For example, two
well-known drugs Gleevec and Tarceva target recep-
tor tyrosine kinase signaling pathways that have a
reported role in cancer [10].
In this work, we develop methods to identify
pathways (Part I) that have a role in disease progres-
sion. Specifically, we ask which pathways are poten-
tially modulated during onset and evolution of im-
mune response to infection. Additionally, we present
a framework (Part II) that can query the differential
activity of ‘any’ pathway between normal and dis-
eased states, thereby allowing for the principled se-
lection of pathway inhibitors to modulate and control
disease. Using time series expression profiles of gene
expression, we use functional data analysis (FDA)
to process, analyze and cluster the data into possible
pathway components. In addition, we use a manifold
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embedding technique to improve on these results and
extend this for generalized pathway querying.
2. OUTLINE
This paper is organized as follows. To interpret
pathway activity during immune response, section
3 deals with the examination of the gene expression
data during pathogen infection, and its representa-
tion in terms of B-spline basis functions. Section 4
uses principal component analysis on the functional
data (fPCA) to discover modes of variation in the
data. This is followed by clustering genes in fPCA
space to find genes whose interaction is putatively as-
sociated with infection. We find that the results are
not directly relevant biologically and hence, section
8 develops methods to improve the context of the
clustering results to obtain more meaningful results.
This new framework enables the solution of another
hitherto unexamined problem - querying any arbi-
trary pathway for co-ordinated differential activity
between case and condition (section 9). As an exam-
ple, we examine the activity of the Toll-like receptor
(TLR) pathway for the pathogen infection data set,
and demonstrate the general utility of this approach
in such problems. Section 11 concludes the paper.
3. DATA EXTRACTION AND
PRE-PROCESSING
One of the most common processes involving gene-
pathway modulation is the systemic response of the
immune system to an invading pathogen. With the
advent of whole genome microarrays that can as-
say the activity of genes over a time course, expres-
sion profiling of genes during the innate and adap-
tive immune response has been actively pursued for
the identification of genes that can be used for di-
agnostic or therapeutic purposes. For this study, in
order to find pathways implicated in the immune re-
sponse to pathogen infection, we use functional ex-
pression data gathered by the Young group [14]. This
data profiles the various gene activation programs
initiated in macrophage cells on exposure to various
pathogens such as tuberculosis, e.coli and staphylo-
coccus aureus. There is also a set of control treat-
ments in which latex beads coated without bacteria
are presented to the macrophage cell population. In
this study, we consider the differential pathway ac-
tivity between tuberculosis and control conditions.
The methods developed in our approach are however,
more general and can be applied for any number of
interesting conditions.
The dataset contains expression values at 8
time points for 168 unique macrophage genes.
These correspond to gene expression profiling
0.5, 1, 3, 6, 12, 16, 18, 24 hours after exposure with the
pathogen (or control). Since macrophages exhibit
an early innate as well as late adaptive immune re-
sponse, it is interesting to examine which genes are
expressed in a certain phase.
To use the functional data approach on the raw
data, we start by representing the functional data
via B-spline basis functions. This choice of basis
functions is primarily governed by the lack of inher-
ent periodicity in immune response over the first 24
hours, as well as the possibility of local structure
in the time series that are are relevant to analysis.
Using the “FDA” package in R, we create B-spline
basis functions (Bk(tj)) of order 3 and J = 46 in-
ternal knots over the interval [0.5, 24]. Under this
representation, we have,
xi(tj) =
∑K
k=1 ckBk(tj) for i = 1, 2, . . . , n with
n = 168.
Furthermore, a smoothing operation is im-
plemented on the data (using generalized cross-
validation), with λ = 0.001. The plots of the func-
tional data after smoothing are displayed in Fig. 1(a)
and Fig. 1(b) respectively.
4. FUNCTIONAL PRINCIPAL
COMPONENT ANALYSIS (fPCA)
Functional PCA (fPCA) aims to find a solution
to the eigenvalue problem [15, 16] : Cφb = λb,
where C = [
∑n
i=1 ci,kci,l/n], φ = [〈Bk, Bm〉] and
b = (b1, b2, . . . , bk). The j
th principal component
eigenvector bj of Cφ leads to an estimate ǫj =
[B1, B2, . . . , BK ]
Tbj of the eigenfunction. With this,
the jth principal component score is given by αi,j =
〈xi, ǫj〉. The set of scores ([αi,1, αi,2, . . . , αi,p] ∈
R
p; i = 1, 2, . . . , 168) can then be used for cluster-
ing [18].
To understand the modes underlying disease on-
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set and its response by the immune system, a fPCA
analysis of the data was done. The first and second
principal components of the tuberculosis functional
data are displayed in Fig. 2 (a) and (b) respectively.
These harmonics correspond to the components af-
ter varimax rotation to aid interpretability (15,16).
The harmonic plots indicate two distinct behaviors
and are indicative of typical immune response.
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(a) Smoothed Control time-series
Data.
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(b) Smoothed Tuberculosis time-
series Data.
Fig. 1. Smoothed functional data for immune response under
tuberculosis and control. The x-axis denotes the time points
in hours.
Some interesting insights emerge from the plots
of Fig. 2. The first harmonic corresponds (roughly)
to the ‘late’ variation in gene expression (Fig. 2(a),
accounting for ∼ 78% variation) whereas the second
principal component corresponds to the ‘early’ vari-
ation (Fig. 2(b), accounting for ∼ 20% variation).
This is extremely meaningful because the principal
components correspond to a drastic change in adap-
tive immune response and is strongly associated with
biological response to pathogen infection. This is
also known from biological literature [14, 7].
The scores of the functional tuberculosis gene
data along these first two principal components is
shown in Fig. 3(a).
5. MODEL-BASED CLUSTERING
Having found scores of each of the genes in fPCA
space, our goal is to now group (cluster) genes with
similar temporal profiles. In this section, we de-
rive the parameter update equations for a Mixture
of Gaussian clustering paradigm [6, 12].
(a)
(b)
Fig. 2. First and Second Functional Principal Components
for Tuberculosis data. X-axis corresponds to assay time
points, as in the previous plots. We note that the solid line
in each case corresponds to the mean function, the (+) line
corresponds to the mean function added to a multiple of the
harmonic and the (−) line corresponds to a subtraction of the
harmonic function.
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We consider the group of gene expression pro-
files G = {g(1), g(2), . . . , g(n)}, all of which share a
common dynamic. Consider gene profile i, g(i) =
[αi,1, αi,2, . . . , αi,J ], a J-dimensional random vector
(here J = 2) which follows a k-component finite mix-
ture distribution described by:
p(g|θ) =
k∑
m=1
αmp(g|φm) (1)
where α1, . . . , αk are the mixing probabilities, each
φm is the set of parameters defining the m
th compo-
nent, and θ ≡ {φ1, . . . , φk, α1, . . . , αk} is the set of
complete parameters needed to specify the mixture.
We have,
αm ≥ 0,m = 1, . . . , k, and
k∑
m=1
αm = 1 (2)
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(b) BIC plot during model-based clustering
Fig. 3. Embedding of data onto fPCA space and BIC plot to
find optimal cluster number.For a set of n independently and identically dis-
tributed samples,
G = {g(1), g(2), . . . , g(n)}, (3)
the log-likelihood of a k-component mixture is given
by:
log p(G |θ) = log
n∏
i=1
p(g(i)|θ) (4)
=
n∑
i=1
log
k∑
m=1
αmp(g
(i)|φm) (5)
• Treat the labels, Z = {z(1), . . . , z(n)}, as-
sociated with the n samples - as missing
data. Each label is a binary vector z(i) =
[z
(i)
1 , . . . , z
(i)
k ], where z
(i)
m = 1 and z
(i)
p = 0,
for p 6= m indicates that sample g(i) was
produced by the mth component.
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In this setting, the Expectation Maximiza-
tion algorithm can be used to derive the cluster pa-
rameter (θ) update equations.
In the E step of the EM algorithm, the function
Q(θ, θˆ(t)) ≡ E[logp(G ,Z |θ)|G , θˆ(t)],is computed.
This yields,
w(i)m ≡ E[z
(i)
m |G , θˆt] =
αˆm(t)p(g
(i)|θˆm(t))∑k
j=1 αˆj(t)p(g
(i)|θˆj(t))
(6)
where w
(i)
m is the posterior probability of the event
z
(i)
m = 1, on observing g
(i)
m .
The estimate of the number of components (k) is
chosen using a bayesian information criterion (BIC)
criterion [6, 12]. The BIC criterion borrows from in-
formation theory and serves to select models of low-
est complexity to explain the data. As can be seen
below, this complexity has two components - the first
encodes the observed data as a function of the model
and the second encodes the model itself. Hence, the
BIC criterion in our setup becomes, :
kˆBIC = argmaxk{2logp(G |θˆ(k))−
k(Np + 1)
2
logn},
(7)
Np is number of parameters per component in the
k component mixture, given the number of clusters
kmin ≤ k ≤ kmax. n is the total number of observa-
tions.
In the M step: For m = 0, 1, . . . , k, θˆm(t + 1) =
argmaxφm Q(θ, θˆ(t)), for m : αˆm(t + 1) > 0, the el-
ements φˆ’s of the parameter vector estimate θˆ are
typically not closed form and depend on the specific
parametrization of the densities in in the mixture,
i.e. p(g(i)|φm). If p(g
(i)|φm) belongs to the Gaus-
sian density N (µm,Σm) class, we have, φ = (µ,Σ)
and EM updates yield 12,
αˆm(t+ 1) =
∑n
i=1 w
(i)
m
n
, (8)
µm(t+ 1) =
∑n
i=1 w
(i)
m g(i)∑n
i=1 w
(i)
m
, (9)
Σm(t+ 1) =
∑n
i=1 w
(i)
m (g(i) − µm(t+ 1))(g
(i) − µm(t+ 1))
T
∑n
i=1 w
(i)
m
(10)
The equations 5. 6, 8, 9, 10 are the parameter
update equations for each of the m = 1, . . . k cluster
components.
The R package ‘MClust’ can be used to do model
based clustering on the genes (represented as fPCA
scores). The method enables the selection of the op-
timal number of clusters via maximizing the bayesian
information criterion (BIC). It outputs a plot that
displays the BIC for each cluster assignment, where
the clusters can have three independent degrees of
freedom (shape, volume and orientation). The opti-
mal cluster assignment is chosen from all possibilities
of shape, volume, orientation and BIC [6].
6. fPCA CLUSTERING RESULTS
Based on the Bayesian Information criterion (BIC),
we select two clusters (Fig. 4(a)) with variable
shape, volume and orientation (VVV). Addition-
ally, to ascertain the purity of clustering, we ex-
amine if co-clustered genes are in the same cellu-
lar location. This is done using the FATIGO+ tool
at http://babelomics.bioinfo.cipf.es/fatigoplus/. The
results of this analysis is in Fig. 4(b). The results in-
dicate that only about 50% of the co-clustered genes
are co-located (in the nucleus). This casts serious
doubts on the analysis methods of previous papers
that use clustering in PCA/fPCA space as a method
to discover novel pathway components. Biologically,
the cellular proximity of two genes is essential for
their interaction along a pathway. Thus, unless cel-
lular proximity can be explicitly incorporated into
this framework, such clustering can potentially fail
in the discovery of true pathway components [1, 11].
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(a) BIC based model clustering.
(b) GO purity of Clusters from fPCA.
Fig. 4. BIC based clustering for fPCA embedded data and
GO cluster purity.
7. COMMENTS
To recapitulate, there is a need to find molecular
signatures that predict grade of disease/ therapeutic
potential. The traditional approach to find dysreg-
ulated pathways is based on clustering genes based
on expression profiles (for the corresponding disease)
– in fPCA space. This uses the hypothesis that co-
clustered (co-expressed) genes are ‘possibly’ part of
the same pathway – since genes with similar expres-
sion profiles all belong to same pathway, i.e. their
relationship is so tight that they will behave in the
same coordinated manner. A lot of literature using
this hypothesis is available.
However, this approach is questionable because
in any biological process, several pathways are in-
volved, and there are cross-interactions (cross-talk)
among pathways. Clusters can thus consist of pu-
tatively interacting pathways, not just one pathway.
Because different conditions/diseases are due to dif-
ferent aberrant pathways, clusters can have different
sets of genes and thus several ‘true’ pathways. This
leads to incorrect inference of the biology, because
every study can find a‘new’ pathway based on which
condition they study. In reality, there are only a few
standard pathways – however their interactions are
different in different diseases/conditions.
Thus, we would need to incorporate some other
prior knowledge to aid the clustering approach in
achieving biological realism. One such way would be
to use location information in conjunction with ex-
pression and cluster genes in that combined space –
this follows from fact that if genes have to have coor-
dinated pathway activity, they should be nearby in
cellular location.
8. Part I: BUILDING REALISM WHILE
CLUSTERING
As suggested in the previous sections, it would be
useful to have a “space” which respects physical
cellular proximities in addition to expression sim-
ilarities. This can be enabled by considering a
set of annotations that describe the “cellular lo-
cation” information for each of the genes (in the
macrophage activation program). One set of anno-
tations that is well researched by the bioinformatics
community is the Gene Ontology (GO) descriptors
(http://www.geneontology.org/ ). This is a controlled
hierarchical vocabulary that annotates genes in var-
ious organisms by cellular component (CC), molecu-
lar function (MF) and biological process (BP), based
on literature reports.
The next section examines the generation of a
“semantic similarity matrix” between genes based
on their GO (CC) descriptors, to quantify the cel-
lular proximity among them. Just like lexical word
ontologies for spoken languages (e.g. WordNet at
http://wordnet.princeton.edu/ ), this structure im-
poses a tree structure on the various GO terms,
thereby expressing the similarity between any two
terms in the ontology as a function of their parents
in the ontology tree.
The next step involves the use of manifold em-
bedding techniques that can integrate such GO sim-
ilarity along with expression-level similarity to con-
struct an embedding of the genes as points in some
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space. One such technique is Laplacian Eigenmaps
[2], also profiled in Section: 8.2 that approximate
both these relationships (semantic and expression
similarities). This is a generalization of the principal
component approach in that the distance measures
on such manifolds are not necessarily euclidian. Af-
ter embedding the genes onto this manifold, we will
then re-examine the model based clustering approach
and assess the GO purity (as in section: 6) of the ob-
tained clusters.
We remind the reader that the main goal here
is to embed genes based on their expression pro-
files, but additionally weighted based on their cel-
lular proximity – this would be more biologically rel-
evant for the discovery of true pathway activity. We
believe that such an approach is consistent with the
rationale of using integrative genomics or principled
heterogeneous data integration for stronger hypoth-
esis generation [20].
8.1. GO Semantic Similarity
To quantify the notion of similarity of terms along
an ontology, we appeal to a vast amount of litera-
ture that addresses such questions [4]. The semantic
similarity of any two GO terms along the ontology
hierarchy is based on the number of shared par-
ents and the information content of the individual
GO terms (measures: Jiang Conrath, Resnik etc.).
Based on the literature, we use the Jiang-Conrath
similarity measure, given by,
Wi,j = sim(ci, cj) =
1
jcdist(ci,cj)
, with
jcdist(ci, cj) = 2log(p(lso(ci, cj))) − [log(p(ci)) +
log(p(cj))]
where ci and cj are two terms (nodes) along the
GO ontology tree (i, j ∈ {1, 2, . . . , 168}). lso(ci, cj)
refers to the the information content of the last com-
mon parent of these two nodes. The information
content is computed based on the probabilities of ob-
serving the individual nodes and their last common
ancestor in an overall corpus.
For the 168 genes profiled in this study, we use
the R package “GOSim” to obtain the semantic sim-
ilarity matrix (size 168× 168) based on GO location
annotation. This similarity matrix is used to obtain
the weight matrixW during the Laplacian Eigenmap
embedding procedure [2] below.
8.2. LLE (Laplacian Eigenmaps)
• Build the K × K, (K = 168) dimensional
weight matrix W from the Gene Ontology
(“Cellular Component”) terms of the genes
in the dataset. This distance is the “normal-
ized” semantic similarity alluded to above
(section 8.1).
• Assign weight Wi,j , from (1) for each gene
pair (i, j), for each of the
(
K
2
)
gene pairs.
Note: The higher this weight, the closer the
genes are.
• Find n nearest neighbors using the euclidian
distance in principal component space. The
scores of the functional data along the first
two principal components can be interpreted
as co-ordinates in a euclidian space.
• Form the Graph Laplacian:
Li,j =


di =
∑
kWi,k if i = j;
−Wi,j if i is connected to j;
0 otherwise.
• Solve: minyy
TLy = 12
∑
i,j(yi −
yj)
2Wi,j (2),
subject to:
– yTDy = 1, and
– yTD1 = 0,
whereDi,i =
∑
j Wj,i, a diagonal weight ma-
trix.
• Embed the co-ordinates to a lower dimen-
sional manifold, using the solution (the
Laplacian Eigenmap) obtained from the
minimization above.
– The solution to (2) is given by the
d generalized eigenvectors associated
with the d smallest generalized eigen-
values solving Ly = λDy (neglecting
the zero eigenvalue and its eigenvector).
– If y = [y1, . . . , yd] is the collection of
these eigenvectors, then the embedding
is given by :
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yi = (yi1, . . . , yid)
T , i.e., the d dimen-
sional representation of the ith data
point (gene).
• In our representation, we take dimensional-
ity, d = 2 and number of neighbors, n = 5.
The final embedding of the functional data
based on expression and location modalities
is shown in Fig. 5(a).
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(b) BIC plot for Eigenmap based clustering.
Fig. 5. Eigenmap based embedding and BIC plot.
8.3. Results with Laplacian Eigenmaps
After transforming the original scores (from fPCA)
based on the GO semantic similarity matrix W , the
2D representation of the gene data is shown in Fig.
5(a). Based on this new embedding, which leads to
a very different visualization of the data compared
to Fig. 3(a), we can once again use model based
clustering in the new space.
Based on this, the BIC plot for the Eigenmap
embedded data is shown in Fig. 5(b). The high-
est BIC corresponds to 8 clusters (Fig. 6(a)) with
variable shape, volume and orientation (VVV). An
examination of the GO (“cellular component” anno-
tation) is shown in Fig. 6(b). This indicates that
the GO enrichment of genes that are close by (like in
nucleus) is much higher (∼ 70% compared to 55% be-
fore). Furthermore, interrogation of a cluster in the
new assignment (after Eigenmap embedding) clearly
identifies known components of the cytokine path-
way [7] (several interleukin members). This shows
that an embedding, that respects location as well as
expression simultaneously, identifies closely interact-
ing pathway components via clustering. This aids in
the development of biologically relevant hypotheses.
(a) Clustering on Eigenmap embedded data.
(b) GO purity of Eigenmap based clustering.
Fig. 6. BIC based clustering for Eigenmap embedded data
and GO purity.
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9. Part II: QUERYING PATHWAY
ACTIVITY
The first part of this work presents a principled
framework to embed gene relationships based on ex-
pression and cellular location. This framework can
now be extended to understand the co-ordinated ac-
tivity of genes constituting a pathway. We note
that this question has not hitherto been asked in
this context previously. Previous methods have only
looked at identifying pathway genes based on expres-
sion similarities. In the light of the previous analysis
suggesting that plain clustering in expression space
without regard to physical proximity might not be
biologically relevant, this framework enables the in-
tegration of multiple modalities to obtain much more
relevant results. Embedding the data using a princi-
pled approach enables the formulation of more com-
plex queries such as coordinated pathway activity.
The key question that can now be addressed un-
der the above framework is: How strongly is pathway
‘X’ dysregulated between normal cells and diseased
(tuberculosis infected) cells. A pathway is a set of
interacting genes. More generally, one can query for
the co-ordinated activity of any subset of interesting
genes (generalizing the approach of [19, 9].
9.1. Querying Pathway Activity
In order to query a pathway’s activity, we can
first obtain the known components (genes) of
the pathway using resources such as the KEGG
(http://www.genome.ad.jp/kegg/pathway.html) or
BioCarta (http://cgap.nci.nih.gov/Pathways/BioCarta Pathways)
pathway repositories.
For any query pathway P (consisting of k
genes),we can find the co-ordinates of this subset on
the manifold embedding obtained above. Let Cp be
the inter-point distance matrix (k× k) of the k-gene
pathway in the eigenmap for the control condition.
Let Tp be the inter-point distance matrix of the k-
gene pathway under the perturbation (tuberculosis
infection).
In this setting, the question of querying path-
way activity translates to the following question:
How are the gene-gene associations among these k-
components of the pathway “different” between con-
trol (Cp) and case (Tp).
This is addressed in the following section. The
idea is to find a metric of similarity (or distance) be-
tween the distance matrices (Cp and Tp). The Mantel
correlation test has been used in ecological studies as
a similarity metric. The other is a hitherto unused
metric, termed the logDet divergence, that has been
used in other applications (to quantify the distribu-
tional divergence between two probability distribu-
tions).
9.2. Quantifying difference in association
matrices
Based on the above, the Mantel’s test is used in eco-
logical analysis (R package “vegan”) to compare two
(or more) spatial proximity matrices. In our context,
we are interested to ask if the gene set that is close
in one space (control) is also close in the other space
(tuberculosis).
The Mantel correlation coefficient between two
(k × k) matrices X and Y - ‘r′ is given by [13 ]:
r = 1(n−1)
∑
i<j
xij−x¯
sx
.
yij−y¯
sy
Here, X = Cp and Y = Tp. sx and sy are
the standard deviations from the entries of the ma-
trices X and Y , respectively (for normalization);
n = k(k−1)2 . The higher the value of ‘r
′, the more
similar the two distance matrices are.
Finally, we can estimate a significance of
r(Tp, Cp) via bootstrapping. This would involve the
following steps:
• Repeat the following procedure B(= 1000)
times (with index b = 1, . . . , B):
– Generate resampled (with replace-
ment) versions of the matrices Cp, Tp,
denoted by Cbp, T
b
p respectively.
– Compute the statistic θb = r(T bp , C
b
p).
• Construct an empirical CDF (cumulative
distribution function) from these boot-
strapped sample statistics, as FΘ(θ) =
P (Θ ≤ θ) = 1
B
∑B
b=1 Ix≥0(x = θ−θ
b), where
I is an indicator random variable on its ar-
gument x.
• Compute the true detection statistic (on the
original time series) θ0 = r(Tp, Cp) and its
corresponding p-value (p0 = 1−FΘ(θ0)) un-
der the empirical null distribution FΘ(θ).
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• If FΘ(θ0) ≥ (1 − α), then we have that
the true mantel correlation value is signifi-
cant at level α, leading to rejection of null-
hypothesis (no association).
9.3. logDet divergence
The logDet divergence has recently received a lot of
interest in the machine learning community, mainly
with regard to metric learning problems [8]. To
see an example of how they arise, consider the the
Kullback-Liebler (KL) divergence between two mul-
tivariate Gaussian densities p(x;Cp) and p(x;Tp).
This is given by:
KL(p(x;Cp)||p(x;Tp)) =
1
2Dld(Cp, Tp), where,
Dld is the logDet divergence between two posi-
tive definite matrices Cp and Tp defined by:
Dld(Cp, Tp) = tr(CpT
−1
p )−logdet(CpT
−1
p )k (k
is the rank of the matrices Cp and Tp)
We note that the distance matrices Cp and Tp
are positive semi-definite, but can be made posi-
tive definite via the addition of a constant term to
its non-diagonal elements [5] (Cailiez method). Be-
fore using the logDet criterion, the distance matrices
need to be converted into correlation matrices (this
can be done via a scaled exponential transforma-
tion [2]. Additionally, since the KL divergence is
not intrinsically symmetric, the symmetrized ver-
sion, LDdist(Tp, Cp) =
1
2Dld(Cp, Tp) +
1
2Dld(Tp, Cp)
can be used instead. The higher the value of this
symmetrized distance, the higher the dissimilarity
between Cp and Tp.
Finally, we can estimate a significance of
LDdist(Tp, Cp) via bootstrapping. This would in-
volve the following steps:
• Repeat the following procedure B(= 1000)
times (with index b = 1, . . . , B):
(1) Generate resampled (with replace-
ment) versions of the matrices Cp, Tp,
denoted by Cbp, T
b
p respectively.
(2) Compute the statistic θb =
LDdist(T
b
p , C
b
p).
• Construct an empirical CDF (cumulative
distribution function) from these boot-
strapped sample statistics, as FΘ(θ) =
P (Θ ≤ θ) = 1
B
∑B
b=1 Ix≥0(x = θ−θ
b), where
I is an indicator random variable on its ar-
gument x.
• Compute the true detection statistic (on the
original time series) θ0 = LDdist(Tp, Cp) and
its corresponding p-value (p0 = 1 − FΘ(θ0))
under the empirical null distribution FΘ(θ).
• If FΘ(θ0) ≥ (1 − α), then we have that the
true logDet value is significant at level α,
leading to rejection of null-hypothesis (com-
plete association).
10. CASE STUDY:TLR PATHWAY
As an example of querying pathway activity, we anal-
yse the toll-like receptor (TLR) pathway. Members
of the toll-like receptor (TLR) gene family convey
signals stimulated by various pathogenic factors, ac-
tivating signal transduction pathways that result in
transcriptional regulation and stimulate innate im-
mune function (Fig. 7(a)). Hence it is one of the
earliest and most strongly activated pathways dur-
ing immune response.
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(a) TLR pathway ( c©Biocarta).
(b) Null Histogram of the logDet divergence for
the TLR pathway. True value=0.5513. Is Acti-
vated Early in Immune Response
Fig. 7. The TLR pathway and its Divergence between nor-
mal and case conditions.
For this pathway, we get the subset of genes that
are common between the Biocarta TLR catalog and
the set of 168 genes. For those 7 genes, we can find
the inter-point distance matrices along the normal
and infection cases. The value (also referred to as
the true value) of the mantel correlation and logDet
divergence (between the normal and control states)
is 0.0447 and 0.5513 respectively, suggesting that the
association between these two distance matrices is
fairly low. Additionally, these correlation and di-
vergence values are significant at the 0.05 level with
respect to the null distribution (Fig. 7(b)). Hence,
these two measures are useful at picking up a truly
activated pathway between these two conditions. In
the same way, one can obtain these two measures for
any chosen pathway of interest, yielding results that
are concordant with literature [7]. This is shown in
Table I.
(a) Null Histogram for the TLR path-
way components. True value=0.5513.
Is Activated Early in IR.
(b) Null Histogram for the Mapk
pathway components. True-value:
0.018. Not activated early.
Fig. 8. Bootstrapping results from Toll-like Receptor (TLR)
and Mapk pathways.
11. CONCLUSIONS
In Part I of this work, we demonstrated a generaliz-
able method to infer pathway components (or cross-
talking pathways). Using Laplacian Eigenmaps, we
were able to co-embed genes based on expression and
location modalities. Model based clustering on em-
bedded data further confirms that genes that are co-
clustered also have higher purity with respect to cel-
lular location. Additionally, some of the co-clustered
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Table 1. Mantel and logDet values of some interesting pathways.
Pathway Name Mantel test (value and significance) logDet divergence (value and significance)
Apoptosis 0.5961(0.038) 0.149(0.025)
Toll-like receptor (TLR) 0.047(0.0255) 0.5513(0.032)
Mapk 0.3373(0.142) 0.018(0.010)
T/B-cell 0.271(0.071) 0.1523(0.006)
genes belong to canonical pathways.
From the 2D space obtained in Part I, we de-
velop a novel framework (Part II) to query the activ-
ity of any gene set (or pathway of interest) across bi-
ological conditions using the Mantel correlation and
logDet divergence.
The overall contribution of this work is the devel-
opment of a complete workflow that combines func-
tional data analysis on expression data with ontol-
ogy to yield biologically relevant results via hetero-
geneous data integration. Though there has been
some previous work [11, 1] combining gene expres-
sion with ontology to understand gene co-regulation,
we are aiming to do this for whole pathways or gene
sets.
12. EXTENSIONS AND FUTURE WORK
The methods developed in this work, both for embed-
ding genes based on expression and cellular location
are applicable for any study of interest and thus eas-
ily generalizable. Additionally, the query for the co-
ordinated activity of any gene set of interest (path-
way or otherwise) is also generalizable since it only
examines the association of the inter-gene distance
matrix (along the manifold) between case and condi-
tion. This procedure also enables a relative ranking
of multiple pathways, thereby allowing for simulta-
neous queries.
This work also expands on previous approaches
in heterogeneous data integration, combining modal-
ities like gene ontology with gene expression specifi-
cally for pathway query along an biological process of
interest. This could further enable efforts to under-
stand pathogenesis through the modulation of path-
way activity between the normal and diseased cell
state.
Finally, though this work uses the Mantel corre-
lation and the logDet divergence for determining the
difference in distance matrices, several other meth-
ods such as Procrustes alignment [3], or the Jensen-
Shannon distributional divergence can be used for
the same purpose. It would be interesting to see
if any of the methods make fewer distributional as-
sumptions on the structure of the inter-point dis-
tance matrices.
AVAILABILITY
The source code of the analysis tools (in R 2.6) is
available on request. The gene expression data is
publicly available at:
http://web.wi.mit.edu/young/.
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